236 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
include the name of the target (or targets) or a summary description of the assets to be acquired and shall confirm that the aggregate purchase … of any Sanctions, (ii) included on OFAC’s List of Specially Designated Nationals or HMT’s Consolidated List of Financial Sanctions Targets, or any
425
uae38w
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
r131uh
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
425
g0knrhg0tq1bc42w9lq7
24 Aug 22
Business combination disclosure
5:21pm
8-K
EX-99.1
zz8oa
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
ay06vjdl91f5rj zx1u
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
4qz7 svze
21 Jun 22
Regulation FD Disclosure
6:19am
425
8ozzrsx1dpvs2ab
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
vda5c9sozyh onlq1l92
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
h1dmdkop51
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-10.1
t2qufeq5 4xpv
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
j7ir2d9n mdir9h0
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
wuvekpz 7veoj
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
gxik3uioru38k fcp4a
23 Mar 22
Business combination disclosure
5:29pm